Skip to main content

Peer Review reports

From: The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

Original Submission
28 Jun 2016 Submitted Original manuscript
27 Nov 2016 Reviewed Reviewer Report - Bruce Joseph Giantonio
1 Dec 2016 Reviewed Reviewer Report - Eliza Hawkes
26 Jan 2017 Author responded Author comments - Goro Nakayama
Resubmission - Version 2
26 Jan 2017 Submitted Manuscript version 2
22 Mar 2017 Author responded Author comments - Goro Nakayama
Resubmission - Version 3
22 Mar 2017 Submitted Manuscript version 3
Publishing
29 Mar 2017 Editorially accepted
4 Apr 2017 Article published 10.1186/s12885-017-3245-1

You can find further information about peer review here.

Back to article page